Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;50(10):913-921.
doi: 10.1111/cup.14482. Epub 2023 Jul 5.

Agminated presentation of fusion-driven melanocytic neoplasms

Mónica Fumero-Velázquez  1 , Michael Hagstrom  1 , Soneet Dhillon  1 , Shantel Olivares  1 , Lawrence J Jennings  2 , David Dittman  2 , Madina Sukhanova  2 , Nicoleta C Arva  3 , Seth D Goldstein  4 , Amy Theos  5 , Peter Pavlidakey  5 , Zachary Carr  1 , Pedram Gerami #  1
Affiliations

Agminated presentation of fusion-driven melanocytic neoplasms

Mónica Fumero-Velázquez et al. J Cutan Pathol. 2023 Oct.

Abstract

Background: The conventionally understood pathogenesis of agminated Spitz nevi includes a mosaic HRAS mutation followed by copy number gains in 11p. However, we have recently observed agminated presentations of fusion-driven melanocytic neoplasms.

Methods: We retrieved cases from our database of benign fusion-induced melanocytic neoplasms with an agminated presentation. Both the primary lesion and the secondary lesion were sequenced. TERT-promoter mutational testing and the melanoma fluorescence in situ hybridization assay were also performed.

Results: Three cases were included. Two had a PRKCA fusion (partners ATP2B4 and MPZL1) and one had a ZCCHC8::ROS1 fusion. None of the cases met morphologic or molecular criteria for malignancy. There was no evidence of tumor progression in secondary lesions. The same fusion was identified in the primary and secondary lesions. None of the patients developed evidence of nodal or systemic metastasis.

Conclusions: We present accumulating evidence that fusion-driven melanocytic neoplasms can present with an agminated presentation. The differential diagnosis of an agminated presentation versus a locally recurrent or potentially locally metastatic tumor is critical, and accurate diagnosis has significant prognostic and therapeutic consequences for the patient. As with HRAS mutations, fusion-driven melanocytic tumors may have an agminated presentation.

Keywords: agminated Spitz nevi; dermatopathology; fusions; genomics; mosaicism.

PubMed Disclaimer

References

REFERENCES

    1. Shin J, Kim YC. Multiple agminated acquired melanocytic nevi. Ann Dermatol. 2013;25(2):251-252. doi:10.5021/ad.2013.25.2.251
    1. Rocha CR, Grazziotin TC, Rey MC, Luzzatto L, Bonamigo RR. Congenital agminated melanocytic nevus-case report. An Bras Dermatol. 2013;88(6 suppl 1):170-172. doi:10.1590/abd1806-4841.20132137
    1. Choi YJ, Kim HS, Lee JY, Kim HO, Park YM. Agminated acquired melanocytic nevi of the common and dysplastic type. Ann Dermatol. 2013;25(3):380-382. doi:10.5021/ad.2013.25.3.380
    1. Boone SL, Busam KJ, Marghoob AA, et al. Two cases of multiple spitz nevi: correlating clinical, histologic, and fluorescence in situ hybridization findings. Arch Dermatol. 2011;147(2):227-231. doi:10.1001/archdermatol.2010.439
    1. Berk DR, Lane AT. Acquired bilateral agminated Spitz nevi in a child with Langerhans cell histiocytosis. Pediatr Dermatol. 2010;27(3):282-284. doi:10.1111/j.1525-1470.2010.01139.x

MeSH terms

Substances

LinkOut - more resources